Portfolio (Quarterly)
Guide ↗
SILVERARC CAPITAL MANAGEMENT, LLC
· CIK 0001816307| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 | — | ABEONA THERAPEUTICS INC | — | 627,738.0 | $3.3M | 0.46% | -367K | -36.9% | $5.27 | — |
| 22 | TELA | TELA BIO INC | Healthcare | 2,647,512.0 | $3.1M | 0.43% | -135K | -4.9% | $1.18 | -29.7% |
| 23 | QURE | UNIQURE NV | Healthcare | 126,047.0 | $3.0M | 0.42% | -329K | -72.3% | $23.93 | +13.0% |
| 24 | — CALL | ULTRAGENYX PHARMACEUTICAL IN | — | 110,000.0 | $2.5M | 0.35% | -418K | -79.2% | $23.00 | — |
| 25 | — | ELUTIA INC | — | 2,751,314.0 | $1.9M | 0.27% | -100K | -3.5% | $0.69 | — |
| 26 | SION | SIONNA THERAPEUTICS INC | Healthcare | 41,460.0 | $1.7M | 0.24% | -67K | -61.9% | $41.14 | -2.2% |
| 27 | RAPP | RAPPORT THERAPEUTICS INC | Healthcare | 9,659.0 | $293K | 0.04% | -194K | -95.3% | $30.34 | +22.2% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%